Project Grant HT9425261E263
- Federal Grant Award Summary The University of Iowa received a $233,250 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded November 1, 2025, with completion scheduled for October 31, 2027. The award funds research focused on targeting Delta-like Ligand 3 (DLL3) with gamma delta T cell engagers to develop novel therapeutic approaches for treating neuroendocrine prostate cancer. This research initiative aligns with...
- Federal Grant Award Summary The University of Iowa received a $742,384 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a clinical trial evaluating pirfenidone as a novel therapeutic intervention for chronic pancreatitis. The award was issued on September 15, 2025, with a one-year performance period concluding on September 14, 2026. The research will be conducted at the University of Iowa's Iowa City campus...
- The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
- The University of Iowa received a $399,990 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2027. The award funds spatial proteogenomics research designed to identify novel prognostic and predictive biomarkers in melanoma. This research initiative directly supports the Defense Health Agency's mission to transform healthcare for service members and the American public...
- Federal Grant Award Summary The Defense Health Agency awarded The University of Iowa a $999,265 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, through August 14, 2028. The research project investigates the impact of obesity-driven gut microbiota alterations on multiple sclerosis severity, addressing a medical condition affecting the military population. Research activities will be conducted at the University of Iowa's Iowa...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant totaling $776,831 under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research on P2 purinergic receptors in pancreatic ductal adenocarcinoma as therapeutic targets, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment...
- The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Iowa State University to develop high-throughput, high-resolution in vitro models of prostate cancer bone marrow metastases. The $1,759,708 award, with a performance period from April 15, 2025 to April 14, 2028, aims to transform healthcare for military service members, veterans, and the broader public through innovative medical...
- Federal Grant Award Summary The University of Iowa received a $1,498,989 Project Grant award effective September 1, 2025, through the Department of Defense (Defense Headquarters Service) under the Basic Scientific Research program (CFDA 12.431). The award, with a completion date of August 31, 2027, supports the "DEPSCOR-CB FY24 Heterogeneous Nanoscale Materials Collaborative for Quantum Technologies" research initiative. This project advances fundamental scientific knowledge in...
- Federal Grant Award Summary The University of Nebraska Medical Center received a $309,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on November 15, 2025, with a completion date of November 14, 2027. The award funds research investigating the role of the axonal guidance molecule neuropilin-2 (NRP2) in promoting perineural invasion (PNI) and pain in pancreatic ductal adenocarcinoma (PDAC) patients. This basic...
The University of Iowa received a $559,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2028. The award supports a novel theranostic strategy for pancreatic neuroendocrine tumors (PNETs), combining diagnostic and therapeutic approaches to advance medical solutions for conditions affecting the military population. This research aligns with the DHA's broad portfolio of biomedical investigations addressing Service Member health and clinical innovation, with the performance location based in Iowa City, Iowa. The two-year funding period supports investigator-initiated research in rare cancer diagnostics and treatment development. This award represents part of the University of Iowa's substantial federal research portfolio, which includes complementary National Cancer Institute funding for neuroendocrine tumor research (a $2.185 million Specialized Programs of Research Excellence award from August 2025) and positions the institution as a key contributor to military medical research priorities within the DHA's competitive grant portfolio.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $560.0k | 6/9/26 |